Patents Assigned to Interpace Diagnostics, LLC
  • miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms
    Patent number: 11118231
    Abstract: The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as thyroid nodules or thyroid cancer, and using the profile in the diagnosis of a patient for a condition, such as thyroid nodules or thyroid cancer.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: September 14, 2021
    Assignee: INTERPACE DIAGNOSTICS, LLC
    Inventors: Sylvie Beaudenon-Huibregtse, Ashish Choudhary
  • Methods and compositions involving miR-135b for distinguishing pancreatic cancer from benign pancreatic disease
    Patent number: 10655184
    Abstract: Provided are methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: May 19, 2020
    Assignee: INTERPACE DIAGNOSTICS, LLC
    Inventors: Alex Adai, Anna Szafranska-Schwarzbach, Bernard Andruss, Stephan Albrecht Hahn
  • miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms
    Patent number: 10150999
    Abstract: The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as thyroid nodules or thyroid cancer, and using the profile in the diagnosis of a patient for a condition, such as thyroid nodules or thyroid cancer.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: December 11, 2018
    Assignee: INTERPACE DIAGNOSTICS, LLC
    Inventors: Sylvie Beaudenon-Huibregtse, Ashish Choudhary
  • Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease
    Patent number: 9644241
    Abstract: Provided are methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: May 9, 2017
    Assignee: Interpace Diagnostics, LLC
    Inventors: Alex Adai, Anna Szafransak-Schwarzbach, Bernard Andruss, Stephan Albrecht Hahn